Topic: Sequence Variants
BioDiscovery Inc. Forms Partnership with Be Creative Lab (Beijing) Co. Ltd. For Distribution of NxClinical Software
BioDiscovery announced today an agreement with Be Creative Lab in Beijing, China to be the exclusive reseller and distributor of BioDiscovery products in China.
BioDiscovery launches NxClinical 4.0, a unique system allowing analysis and interpretation of CNV, SNV, and AOH from a single NGS assay
BioDiscovery launches NxClinical 4.0, a unique system allowing analysis and interpretation of CNV, SNV, and AOH from a single NGS assay.
GENALICE and BioDiscovery Partner to Empower Rapid NGS Data Interpretation
GENALICE and BioDiscovery announce a co-marketing partnership to offer their products together as a turn-key end-to-end solution for the use of next-generation sequencing (NGS) data to interpret genomes.
BioDiscovery to announce NxClinical 3.0, a new software to unite data from arrays and NGS, at ASHG 2016
NxClinical 3.0 will be launched during the ASHG 2016 Meeting, October 18-21 in Vancouver, BC, Canada
